Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral HaemorrhaGe (ASPIRING)-Pilot Phase

NCT04522102 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Intracerebral Hemorrhage

Interventions

DRUG: Start antiplatelet monotherapy

Sponsor

The George Institute for Global Health, China

Collaborators

[object Object]
[object Object]
[object Object]